Posterior Reversible Encephalopathy Syndrome During Ipilimumab Therapy for Malignant MelanomaMichela Maur, PierFranco Conte, Chiara Tomasello et al.|Journal of Clinical Oncology|2011Cited by 128
GMP-manufactured density gradient media for optimized mesenchymal stromal/stem cell isolation and expansionGiulia Grisendi, Massimo Dominici, Cecilia Annerén et al.|Cytotherapy|2010Cited by 70
Impressive Response to Dose-Dense Chemotherapy in a Patient with NUT Midline CarcinomaMichela Maur, PierFranco Conte, Angela Toss et al.|American Journal of Case Reports|2015Cited by 21
Predictive Value of Biologic Parameters for Primary Chemotherapy in Operable Breast CancerAntonio Frassoldati, PierFranco Conte, Michela Maur et al.|Clinical Breast Cancer|2005Cited by 6
Everolimus (EVE) and exemestane (EXE) in patients with advanced breast cancer aged ≥ 65 years: new lessons for clinical practice from the EVA studyMarina Elena Cazzaniga, Valter Torri, Claudio Verusio et al.|Oncotarget|2018Cited by 4